| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-71278 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34902-1mg | |||
| Carrier-Free | NBP2-34902-100ug | |||
| Carrier-Free | NBP2-34902-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61706-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34889-5ug | |||
| Carrier-Free | NBP2-34889-1000ug | |||
| Carrier-Free | NBP2-34889-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-59637-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-36490SS | |||
| Azide and BSA Free | NBP2-80685 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-27339SS | |||
| Azide and BSA Free | NBP2-80805 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54457-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-27345SS | |||
| Azide and BSA Free | NBP2-80793 | |||
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0012.jpg "Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human bladder tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)")
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0001.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human Kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0002.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0003.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0004.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0005.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human lung tissue.(Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0006.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0007.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human pancreas tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0008.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human thyroid tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0009.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human endometrium tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0010.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0011.jpg)
![Immunohistochemistry: CCL19/MIP-3 beta Antibody (2A12) [NBP2-46082] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/CCL19-MIP-3-beta-Antibody-2A12-Immunohistochemistry-NBP2-46082-img0013.jpg)
![SDS-Page: Human IL-7 Protein [NBP2-34902] - MW= Approximately 17 kDa](http://images.novusbio.com/fullsize/Human-IL-7-Protein-SDS-Page-NBP2-34902-img0001.jpg "SDS-Page: Human IL-7 Protein [NBP2-34902] - MW= Approximately 17 kDa")
![Western Blot: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis using BCL2L2 mAb against HEK293 (1) and BCL2L2 (AA: 6-118)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-Western-Blot-NBP2-61706-img0008.jpg "Western Blot: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis using BCL2L2 mAb against HEK293 (1) and BCL2L2 (AA: 6-118)-hIgGFc transfected HEK293 (2) cell lysate.")
![Immunocytochemistry/Immunofluorescence: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis of Hela cells using BCL2L2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Goat anti-Mouse IgG (H+L) DyLight 488 secondary antibody was used.](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-Immunocytochemistry-Immunofluorescence-NBP2-61706-img0004.jpg)
![Immunohistochemistry: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis of paraffin-embedded ovarian cancer tissues using BCL2L2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-Immunohistochemistry-NBP2-61706-img0006.jpg)
![Flow Cytometry: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis of K562 cells using BCL2L2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-Flow-Cytometry-NBP2-61706-img0003.jpg)
![Western Blot: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis using BCL2L2 mAb against human BCL2L2 (AA: 6-118) recombinant protein. (Expected MW is 38.2 kDa)](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-Western-Blot-NBP2-61706-img0007.jpg)
![Western Blot: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis using BCL2L2 mouse mAb against HCT116 (1), LOVO (2), SW480 (3), and HL-60 (4) cell lysate.](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-Western-Blot-NBP2-61706-img0009.jpg)
![Immunohistochemistry: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis of paraffin-embedded cervical cancer tissues using BCL2L2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-Immunohistochemistry-NBP2-61706-img0005.jpg)
![Flow Cytometry: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Analysis of Hela cells using BCL2L2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-Flow-Cytometry-NBP2-61706-img0002.jpg)
![ELISA: BCL-W/BCL2L2 Antibody (4G12E6) [NBP2-61706] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/BCL-W-BCL2L2-Antibody-4G12E6-ELISA-NBP2-61706-img0001.jpg)
![Western Blot: IL-31 Antibody (8-C3) [NBP2-80396] - Analysis of IL-31 on recombinant protein lysate using anti-IL-31 antibody at 1/500 dilution.](http://images.novusbio.com/fullsize/IL-31-Antibody-8-C3-Western-Blot-NBP2-80396-img0006.jpg "Western Blot: IL-31 Antibody (8-C3) [NBP2-80396] - Analysis of IL-31 on recombinant protein lysate using anti-IL-31 antibody at 1/500 dilution.")
![Immunocytochemistry/Immunofluorescence: IL-31 Antibody (8-C3) [NBP2-80396] - Staining IL-31 (green) in MCF-7 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/IL-31-Antibody-8-C3-Immunocytochemistry-Immunofluorescence-NBP2-80396-img0003.jpg)
![Immunohistochemistry-Paraffin: IL-31 Antibody (8-C3) [NBP2-80396] - Analysis in human spleen tissue using IL-31 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/IL-31-Antibody-8-C3-Immunohistochemistry-Paraffin-NBP2-80396-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: IL-31 Antibody (8-C3) [NBP2-80396] - Staining IL-31 (green) in A431 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/IL-31-Antibody-8-C3-Immunocytochemistry-Immunofluorescence-NBP2-80396-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: IL-31 Antibody (8-C3) [NBP2-80396] - Staining IL-31 (green) in LOVO cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilized with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/IL-31-Antibody-8-C3-Immunocytochemistry-Immunofluorescence-NBP2-80396-img0002.jpg)
![Immunohistochemistry-Paraffin: IL-31 Antibody (8-C3) [NBP2-80396] - Analysis in human tonsil tissue using IL-31 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/IL-31-Antibody-8-C3-Immunohistochemistry-Paraffin-NBP2-80396-img0004.jpg)
![SDS-Page: Recombinant Human EGF Protein [NBP2-61377]](http://images.novusbio.com/fullsize/Recombinant-Human-EGF-Protein-SDS-Page-NBP2-61377-img0002.jpg "SDS-Page: Recombinant Human EGF Protein [NBP2-61377]")
![SDS-Page: Human Bcl-2 Protein [NBP2-34889]](http://images.novusbio.com/fullsize/Human-Bcl-2-Protein-SDS-Page-NBP2-34889-img0001.jpg "SDS-Page: Human Bcl-2 Protein [NBP2-34889]")
![Western Blot: Cyr61/CCN1 Antibody (3A7.1B8) [NBP2-36490] - WB analysis of (A) 12kDa Partial Recombinant Cyr61/CCN1 protein and (B) Human Liver lysate using Cyr61/CCN1 antibody (clone 3A7.1B8) at 4ug/ml concentration.](http://images.novusbio.com/fullsize/Cyr61-CCN1-Antibody-3A7-1B8-Western-Blot-NBP2-36490-img0004.jpg "Western Blot: Cyr61/CCN1 Antibody (3A7.1B8) [NBP2-36490] - WB analysis of (A) 12kDa Partial Recombinant Cyr61/CCN1 protein and (B) Human Liver lysate using Cyr61/CCN1 antibody (clone 3A7.1B8) at 4ug/ml concentration.")
![Immunohistochemistry-Paraffin: Cyr61/CCN1 Antibody (3A7.1B8) [NBP2-36490] - IHC analysis of formalin-fixed paraffin-embedded tissue section of human liver using Cyr61/CCN1 antibody (clone 3A7.1B8) at 5 ug/ml concentration. The hepatocytes generated a specific cytoplasmic staining with no signal in the cellular nuclei or the sinusoids.](http://images.novusbio.com/fullsize/Cyr61-CCN1-Antibody-3A7-1B8-Immunohistochemistry-Paraffin-NBP2-36490-img0003.jpg)
![Immunohistochemistry-Paraffin: Cyr61/CCN1 Antibody (3A7.1B8) [NBP2-36490] - IHC analysis of formalin-fixed paraffin-embedded tissue section of human hepatocellular carcinoma using Cyr61/CCN1 antibody (clone 3A7.1B8) at 5 ug/ml concentration. The cancer cells generated a specific cytoplasmic staining with some staining in the inter-cellular spaces but no signal in the cellular nuclei, tumor stroma or the RBCs.](http://images.novusbio.com/fullsize/Cyr61-CCN1-Antibody-3A7-1B8-Immunohistochemistry-Paraffin-NBP2-36490-img0001.jpg)
![Immunohistochemistry-Paraffin: Cyr61/CCN1 Antibody (3A7.1B8) [NBP2-36490] - IHC analysis of formalin-fixed paraffin-embedded tissue section of human Renal Cell Carcinoma using Cyr61/CCN1 antibody (clone 3A7.1B8) at 5 ug/ml concentration. The cancer cells generated a specific cytoplasmic staining with some staining in the inter-cellular spaces but no signal in the cellular nuclei, tumor stroma or the RBCs.](http://images.novusbio.com/fullsize/Cyr61-CCN1-Antibody-3A7-1B8-Immunohistochemistry-Paraffin-NBP2-36490-img0002.jpg)
![Western Blot: IL-22 Antibody (8F11E2) [NBP2-27339] - Analysis of IL-22 in A) recombinant protein and B) human spleen lysate using IL-22 antibody at 1 ug/mL. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IL-22-Antibody-8F11E2-Western-Blot-NBP2-27339-img0004.jpg "Western Blot: IL-22 Antibody (8F11E2) [NBP2-27339] - Analysis of IL-22 in A) recombinant protein and B) human spleen lysate using IL-22 antibody at 1 ug/mL. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Immunohistochemistry-Paraffin: IL-22 Antibody (8F11E2) [NBP2-27339] - Analysis of a FFPE tissue section of human tonsil using 5 ug/ml dilution of IL-22 (8F11E2) antibody. The staining was developed using HRP labeled anti-mouse secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin.](http://images.novusbio.com/fullsize/IL-22-Antibody-8F11E2-Immunohistochemistry-Paraffin-NBP2-27339-img0005.jpg)
![Western Blot: Galectin-1 Antibody (GAL1/1831) [NBP2-53212] - Western Blot Analysis of JEG-3 and K562 cell lysate using Galectin-1 antibody (GAL1/1831).](http://images.novusbio.com/fullsize/Galectin-1-Antibody-GAL1-1831-Western-Blot-NBP2-53212-img0006.jpg "Western Blot: Galectin-1 Antibody (GAL1/1831) [NBP2-53212] - Western Blot Analysis of JEG-3 and K562 cell lysate using Galectin-1 antibody (GAL1/1831).")
![Immunocytochemistry/Immunofluorescence: Galectin-1 Antibody (GAL1/1831) [NBP2-53212] - Confocal immunofluorescence image of HeLa cells using Galectin-1 Antibody (GAL1/1831). Green (CF488) and Red Dot is used to label the nuclei Red.](http://images.novusbio.com/fullsize/Galectin-1-Antibody-GAL1-1831-Immunocytochemistry-Immunofluorescence-NBP2-53212-img0003.jpg)
![Immunohistochemistry-Paraffin: Galectin-1 Antibody (GAL1/1831) [NBP2-53212] - Formalin-fixed, paraffin-embedded Human Prostate Carcinoma stained with Galectin-1 Monoclonal Antibody (GAL1/1831).](http://images.novusbio.com/fullsize/Galectin-1-Antibody-GAL1-1831-Immunohistochemistry-Paraffin-NBP2-53212-img0001.jpg)
![Western Blot: Galectin-1 Antibody (GAL1/1831) [NBP2-53212] - Western Blot of HeLa, A431, K562 and 293 Cell Lysates using Galectin-1 Monoclonal Antibody (GAL1/1831).](http://images.novusbio.com/fullsize/Galectin-1-Antibody-GAL1-1831-Western-Blot-NBP2-53212-img0002.jpg)
![Western Blot: Galectin-1 Antibody (GAL1/1831) [NBP2-53212] - Western Blot Analysis of human HeLa cell lysate using Galectin-1 Antibody (GAL1/1831).](http://images.novusbio.com/fullsize/Galectin-1-Antibody-GAL1-1831-Western-Blot-NBP2-53212-img0005.jpg)
![Protein Array: Galectin-1 Antibody (GAL1/1831) [NBP2-53212] - Analysis of Protein Array containing more than 19,000 full-length human proteins using Galectin-1 Antibody (GAL1/1831). Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (MAb) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProt(TM) array. Z-scores are described in units of standard deviations (SD's) above the mean value of all signals generated on that array. If targets on HuProt(TM) are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD's) between the Z-score. S-score therefore represents the relative target specificity of a MAb to its intended target. A MAb is considered to specific to its intended target, if the MAb has an S-score of at least 2.5.](http://images.novusbio.com/fullsize/Galectin-1-Antibody-GAL1-1831-Protein-Array-NBP2-53212-img0004.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Analysis of Interleukin-1 beta in A) full-length recombinant protein and B) human ThP1 lysate using Interleukin-1 beta antibody at 1 ug/ml and 5 ug/ml, respectively. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-43N3D8-Western-Blot-NBP2-27345-img0008.jpg "Western Blot: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Analysis of Interleukin-1 beta in A) full-length recombinant protein and B) human ThP1 lysate using Interleukin-1 beta antibody at 1 ug/ml and 5 ug/ml, respectively. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![<b>Biological Strategies Validation. </b>Flow Cytometry: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Intracellular staining of Interleukin-1 beta positive T cells (upper panel) & monocytes (lower panel) from stimulated PBMC (with a cocktail of TLR ligands and PMA/IM for 6h) using Interleukin-1 beta antibody at 0.5 ug/10^6 cells.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-43N3D8-Flow-Cytometry-NBP2-27345-img0006.jpg)
![Western Blot: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Analysis of full length human IL-1 beta recombinant protein (10ng/well) using IL1 beta Antibody (NBP2-27345) at 1:1000 (left lane) and 1:100 (right lane).](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-43N3D8-Western-Blot-NBP2-27345-img0009.jpg)
![Immunohistochemistry-Paraffin: IL-1 beta/IL-1F2 Antibody (43N3D8) [NBP2-27345] - Analysis of Interleukin-1 beta in human kidney tissue using Interleukin-1 beta antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/IL-1-beta-IL-1F2-Antibody-43N3D8-Immunohistochemistry-Paraffin-NBP2-27345-img0007.jpg)
![ELISA: Mouse SPARC ELISA Kit (Colorimetric) [NBP2-68075] - Samples were spiked with high concentrations of Mouse SPARC and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.](http://images.novusbio.com/fullsize/nbp2-68075_mouse-sparc-elisa-kit-colorimetric-132202416102219.jpg "ELISA: Mouse SPARC ELISA Kit (Colorimetric) [NBP2-68075] - Samples were spiked with high concentrations of Mouse SPARC and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.")
![ELISA: Mouse SPARC ELISA Kit (Colorimetric) [NBP2-68075] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp2-68075_mouse-sparc-elisa-kit-colorimetric-4320249151693.jpg)